Funding to stop Candida auris lacking

A high proportion of people who have been diagnosed with C. auris have died


Scientists who work in mycology — the study of fungi — say there is precious little money available to study Candida auris, according to an article on the STAT News website.

Candida auris is making news for its ability to resist multiple antifungal drugs and settle into hospital rooms so persistently it can take renovations to get rid of it.

The head of mycotic diseases at the Centers for Disease Control and Prevention (CDC) acknowledged his field hasn’t attracted the same kind of research dollars as other pathogens.

A high proportion of people who have been diagnosed with C. auris have died — the CDC estimates it’s between 30 percent and 60 percent.

Read the article.



July 16, 2019


Topic Area: Infection Control


Recent Posts

Wesley Rehabilitation Center Specializes in Patients from Design to Care

Barge knew that patients were at the core of the design process.


Casa Colina Center for Disorders of Consciousness Officially Opens

New program addresses critical need for patients with severe brain injuries.


Legionella Detected at Michigan Health Facility

Case follows a similar finding of Legionnaires’ disease in a former patient.


Crystal Spring Tower Opens at Carilion Roanoke Memorial Hospital

The new cardiovascular institute improves access and care across the region.


Hospital Evacuation Highlights Importance of Emergency Preparedness

Berger Hospital was evacuated after smoke was discovered in the basement.


 
 


FREE Newsletter Signup Form

News & Updates | Webcast Alerts
Building Technologies | & More!

 
 
 


All fields are required. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

 
 
 
 

Healthcare Facilities Today membership includes free email newsletters from our facility-industry brands.

Facebook   Twitter   LinkedIn   Posts

Copyright © 2023 TradePress. All rights reserved.